Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$459.92
$459.06
$274.98
$503.24
$809.46M0.6923,283 shsN/A
Haemonetics Co. stock logo
HAE
Haemonetics
$63.05
-1.4%
$62.82
$55.30
$97.97
$3.17B0.41689,703 shs552,251 shs
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$27.79
-2.8%
$32.86
$23.77
$49.45
$1.87B0.431.01 million shs1.41 million shs
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$13.90
-0.4%
$14.79
$12.16
$30.78
$2.77B0.922.98 million shs3.68 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%0.00%0.00%0.00%+9.50%
Haemonetics Co. stock logo
HAE
Haemonetics
+2.31%+8.07%+1.54%-6.36%-30.08%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-1.31%+16.84%-18.09%-34.33%-27.39%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
+0.58%+7.14%-6.56%-28.94%-54.55%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/AN/AN/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
4.6271 of 5 stars
4.42.00.04.33.61.71.3
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
4.4311 of 5 stars
3.14.00.03.81.51.72.5
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
4.8967 of 5 stars
4.12.04.23.83.03.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
0.00
N/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
2.78
Moderate Buy$101.2260.54% Upside
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
2.29
Hold$46.8368.53% Upside
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
2.14
Hold$21.2552.88% Upside

Current Analyst Ratings Breakdown

Latest ATRI, HAE, XRAY, and QDEL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/30/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$20.00 ➝ $16.00
4/21/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$38.00 ➝ $25.00
4/15/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$14.00
3/18/2025
Haemonetics Co. stock logo
HAE
Haemonetics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$108.00 ➝ $104.00
3/13/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
3/13/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
2/28/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$20.00 ➝ $19.00
2/28/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$24.00 ➝ $20.00
2/28/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$22.00 ➝ $20.00
2/28/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $23.00
2/14/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$20.00
(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$181.60M4.46$19.68 per share23.37$138.02 per share3.33
Haemonetics Co. stock logo
HAE
Haemonetics
$1.37B2.31$6.02 per share10.48$18.05 per share3.49
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$2.78B0.67$21.54 per share1.29$44.75 per share0.62
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$3.79B0.73$3.55 per share3.92$15.55 per share0.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$10.6443.23N/A10.60%7.75%7.12%N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$117.56M$2.5424.8212.511.119.47%23.66%8.82%5/8/2025 (Estimated)
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-$2.03B-$30.28N/A8.66N/A-72.84%3.78%1.80%5/7/2025 (Estimated)
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-$132M-$4.55N/A7.321.80-10.59%12.62%5.45%5/8/2025 (Estimated)

Latest ATRI, HAE, XRAY, and QDEL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
Haemonetics Co. stock logo
HAE
Haemonetics
$1.22N/AN/AN/A$329.38 millionN/A
5/8/2025Q1 2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.30N/AN/AN/A$854.75 millionN/A
5/7/2025Q1 2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$0.61N/AN/AN/A$694.97 millionN/A
2/12/2025Q4 2024
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$1.07$0.63-$0.44-$2.28N/AN/A
2/6/2025Q3 2025
Haemonetics Co. stock logo
HAE
Haemonetics
$1.20$1.19-$0.01$0.74$354.46 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.801.91%+9.65%82.71%21 Years
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.644.60%+14.17%N/A 13 Years

Latest ATRI, HAE, XRAY, and QDEL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
quarterly$0.163.4%3/28/20253/28/20254/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.18
3.06
Haemonetics Co. stock logo
HAE
Haemonetics
1.35
3.97
2.55
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.71
1.22
0.69
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.72
1.25
0.84

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
99.00%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
95.70%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
Haemonetics Co. stock logo
HAE
Haemonetics
1.80%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.79%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7201.76 million1.36 millionNot Optionable
Haemonetics Co. stock logo
HAE
Haemonetics
2,82050.24 million49.33 millionOptionable
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
7,00067.46 million66.58 millionOptionable
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
15,000199.29 million197.75 millionOptionable

Recent News About These Companies

Dentsply Sirona price target lowered to $16 from $18 at Mizuho

New MarketBeat Followers Over Time

Media Sentiment Over Time

Atrion stock logo

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Haemonetics stock logo

Haemonetics NYSE:HAE

$63.05 -0.92 (-1.44%)
As of 03:59 PM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

QuidelOrtho stock logo

QuidelOrtho NASDAQ:QDEL

$27.79 -0.79 (-2.76%)
As of 04:00 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

DENTSPLY SIRONA stock logo

DENTSPLY SIRONA NASDAQ:XRAY

$13.90 -0.05 (-0.36%)
As of 04:00 PM Eastern

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina